Ilex Medical

Ilex Medical FCF Margin

The Free Cash Flow Margin of Ilex Medical (ILX.TA) as of Oct 22, 2026 is 3.09 %. In the previous year, Free Cash Flow Margin was 4.74 % — a change of -34.95% (lower).

FCF Margin

3.09 %

YoY

-34.95%

Last updated:

Free Cash Flow Margin of Ilex Medical is 2023 3.09 % . Free Cash Flow Margin of Ilex Medical was 2022 4.74 % . It decreases by -34.95% lower compared to the previous year.

The Ilex Medical FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2016
-0.37 ILS
Jan 1, 2017
9.91 ILS
Jan 1, 2018
5.67 ILS
Jan 1, 2019
8.46 ILS
Jan 1, 2020
14.37 ILS
Jan 1, 2021
21.49 ILS
Jan 1, 2022
4.74 ILS
Jan 1, 2023
3.09 ILS
The Ilex Medical FCF Margin history
YEARFCF MarginYoY
3.09 %-34.95%
4.74 %-77.93%
21.49 %+49.55%
14.37 %+69.89%
8.46 %+49.10%
5.67 %-42.73%
9.91 %-2,767.84%
-0.37 %-109.25%
4.02 %-74.50%
15.75 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ilex Medical Stock analysis

What does Ilex Medical do? Ilex Medical Ltd supplies in vitro diagnostic equipment and laboratory management software, targeting healthcare providers and laboratories. The company offers nucleic acid testing (NAT) blood screening solutions, cancer screening products, retro virus load monitoring, TB and STD testing systems, and blood sugar monitoring devices. Its subsidiaries include Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd, and Medtechnica Ltd, which support its diagnostic equipment and software distribution. Healthcare facilities and diagnostic laboratories purchase these products for clinical testing and patient management. Ilex Medical Ltd's revenue streams come from selling diagnostic equipment, reagent systems, and laboratory information systems (LIS) to healthcare institutions. The firm's NAT blood screening solutions and infectious disease testing systems are key products for blood banks and public health labs. Subsidiaries like Orsyx-LIS provide specialized laboratory management software, enhancing the company's offerings in the diagnostic software segment. Hospitals and clinics rely on these solutions for efficient diagnostic workflows. The company serves segments including hospitals, blood banks, public health laboratories, and clinics focused on infectious disease management. Products such as cancer screening tools and retro virus load systems are sold to specialized medical facilities. Ilex South Africa and Medtechnica Ltd extend the company's reach in regional markets, supporting localized sales and service. Diagnostic software from Orsyx-LIS is integrated into laboratory workflows for improved data management. Ilex Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ilex Medical stock

Free Cash Flow Margin of Ilex Medical is 3.09 % in 2023.

Free Cash Flow Margin of Ilex Medical changed from 4.74 % to 3.09 %, representing a -34.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Ilex Medical since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Ilex Medical with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Ilex Medical

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Ilex Medical